Replies to post #25687 on Marker Therapeutics Inc (MRKR)

[wolfden2018]

Their treatment works, no side effects, low cost average 11k outpatient treatment vs $80k inpatient treatment, low share structure, institutions just starting to buy, and the investment community does not know about it. Very few followers. That is why it is a gem! Oh, and huge pipeline.